Inquiry Basket
Loading ......
Histone H3 sits at the heart of how eukaryotic cells package and interpret their genome. Together with H2A, H2B, and H4, it forms the octameric core around which roughly 147 base pairs of DNA are wrapped to make a nucleosome, the repeating unit of chromatin. Because the nucleosome both compacts meters of DNA into the nucleus and gates access to that DNA, the precise composition and chemistry of histone H3 have outsized consequences for nearly every DNA-templated process — replication, transcription, repair, and chromosome segregation. Research has shown that histone H3 is not a single uniform protein but a family of closely related variants deposited by different machineries and decorated by a rich set of chemical modifications, together forming a regulatory layer that cells read continuously.
The nucleosome core particle is built from two copies each of H2A, H2B, H3, and H4. Histone H3 pairs with H4 to form a stable (H3-H4)2 tetramer that sits at the center of the particle, while the two H2A-H2B dimers cap the ends. The structure positions the globular domains of H3 to contact DNA at the entry and exit points of the wrap, so that even small changes in the H3 sequence can alter how tightly DNA is held and how easily the nucleosome is moved or evicted. Each H3 molecule also carries a flexible N-terminal tail that extends outward from the core and is exposed to the cellular machinery that writes, reads, and erases chemical marks. Because this tail is largely unstructured, it acts as a modular scaffold where multiple residues can be modified independently, allowing a single nucleosome to carry combinatorial information. The centrality of H3 to nucleosome stability means that its variants and modifications are not decorative additions but direct determinants of chromatin state.
Figure 1. Schematic drawing of a nucleosome with the four canonical histones. (Source: Cui L, et al. 2010)
In most organisms histone H3 exists as several variants that differ by only a handful of amino acids yet are handled by distinct cellular pathways. The canonical forms, H3.1 and H3.2, are encoded by clustered genes whose expression peaks during the DNA synthesis phase and are incorporated in a replication-coupled manner, so freshly made H3 fills the gaps as new DNA is synthesized. By contrast, the replacement variant H3.3 is expressed throughout the cell cycle and deposited independently of replication, most heavily at active genes, regulatory elements, and heterochromatic landmarks such as telomeres. The genome is thus a mosaic: replication-coupled H3 maintains bulk chromatin during division, while replication-independent H3.3 continuously renews nucleosomes at sites of high turnover. Research has shown that the balance between these variants shapes chromatin plasticity and helps define cellular identity, and that mutations affecting H3.3 or its deposition machinery are recurring features of certain tumors and developmental disorders.
The regulatory power of histone H3 derives largely from post-translational modifications clustered on its N-terminal tail and, to a lesser extent, on internal residues. These marks include methylation, acetylation, phosphorylation, and ubiquitination, each placed by dedicated enzyme families and removed by counterpart erasers. Methylation is particularly information-rich because a single lysine can carry none, one, two, or three methyl groups, and each state can be read by a different set of proteins. Acetylation generally neutralizes the positive charge of lysine and is associated with open, transcriptionally permissive chromatin, whereas phosphorylation of serines and threonines is often a rapid, signal-dependent switch linked to mitosis or stress responses. The collection of marks on a nucleosome functions less like a simple on-off switch and more like a combinatorial code that recruiting proteins interpret to decide whether a stretch of DNA should be silent, active, or poised for change.
Figure 2. Known post-translational modifications of N-terminal tails in histones H3 and H4. (Source: Gacek A, et al. 2012)
Among the methylation sites on histone H3, four lysines span the major chromatin states. Methylation of lysine 4, found near promoters and enhancers, is associated with active transcription and helps recruit machinery that opens chromatin and sustains expression. Methylation of lysine 9, by contrast, is a hallmark of silent heterochromatin; it is enriched at repetitive DNA and pericentromeric regions, where it reinforces compaction and restricts the movement of transposable elements. Lysine 27 trimethylation is deposited by Polycomb complexes and labels developmentally repressed genes, keeping them silent until a cell is ready to act. Lysine 36 methylation is laid down across gene bodies during transcription elongation and is linked to productive elongation and the suppression of spurious initiation within genes. Research has shown that these marks are interpreted together, so that the local pattern of H3 methylation helps determine whether a locus is poised, active, or stably repressed, making the methylation landscape a dynamic readout of cellular state.
Beyond methylation, phosphorylation of histone H3 is one of the most visible chromatin changes tied to the cell cycle. Phosphorylation of a specific serine on the H3 tail rises sharply as cells enter mitosis, where it contributes to the condensation of chromosomes and the reorganization of chromatin that allows segregation to proceed. This modification is added by dedicated kinases and removed as cells exit division, so its presence marks a transient, genome-wide shift in chromatin architecture rather than a stable epigenetic state. Other residues on H3 can be phosphorylated in response to DNA damage or stress, recruiting repair factors to the site of insult. The contrast between stable methylation marks and labile phosphorylation illustrates the two timescales on which histone H3 operates: a slow, heritable layer of methylation that defines cellular identity, and a fast, signal-driven layer that lets the cell respond within minutes to division or damage.
The replacement variant H3.3 reaches chromatin through dedicated chaperone systems that distinguish it from the canonical H3 forms. One pathway centers on the HIRA complex, which deposits H3.3 at active promoters, enhancers, and gene bodies in step with transcription. A second pathway depends on the ATRX-DAXX complex, which places H3.3 at telomeres and other repetitive heterochromatic regions, helping maintain silencing and genome stability. Research has shown that these two axes are not redundant: loss of the ATRX-DAXX route is linked to defects in telomere maintenance and to a recombination-based mechanism that some cancer cells use to sustain their chromosome ends. The existence of parallel deposition systems means that H3.3 abundance and location are actively managed, and that the same variant can serve very different functions depending on which chaperone delivers it.
Because histone H3 sits at the intersection of packaging and regulation, it is a frequent target in disease. A striking class of alterations involves single amino-acid substitutions in the H3 proteins themselves, often described as oncohistones, which act in a dominant fashion to remodel the methylation landscape of the entire nucleus. Substitutions at lysine 27 of H3.3 or H3.1, for example, impair the deposition of repressive methylation at that residue and are strongly associated with aggressive midline brain tumors in children, where they drive widespread changes in gene expression. Substitutions at lysine 36 of H3 have been linked to soft-tissue tumors, where they alter the methylation of gene bodies and disrupt normal differentiation programs. Research has shown that these mutant histones behave like molecular sinks, sequestering the enzymes that would normally modify wild-type H3 and thereby shifting chromatin state across the genome. Because the alterations reside in the histone itself rather than in a regulatory enzyme, they illustrate how a single residue in a structural protein can reconfigure epigenetics on a global scale — and why reagents that distinguish mutant from wild-type H3 are valuable for diagnosis and research.
Studying histone H3 in practice depends on tools that can resolve its variants and marks with specificity. Antibodies that recognize a particular modified residue, such as trimethylated lysine 27, are central to methods that map marks across the genome and to assays that measure them in bulk, and careful validation is required because closely related methylation states can cross-react. Chromatin immunoprecipitation followed by sequencing has made it possible to see where each mark sits at high resolution, while mass spectrometry can quantify the full spectrum of H3 modifications and variants in a sample. For the research and diagnostics community, the value of reagents tracks directly with their specificity: an antibody or standard that cleanly distinguishes one H3 variant or one methylation state from another is what allows a measurement to be trusted. As interest in histone-based biomarkers grows, the demand for well-characterized H3 reagents — defined-specificity antibodies, recombinant histone standards, and validated controls — continues to rise.
References
| Target | Cat. No. | Product Name | Size | Species | Application | Detection Sample | |
| HIST1H3A | DEIA-XYA798 | Histone H3 ELISA Kit | 96T | Qualitative | Cultured cells | Inquiry | |
| DEIA-XYA799 | Histone H3 (Phospho-Ser10) ELISA Kit | 2 x 96T | Qualitative | Cultured cells | Inquiry | ||
| DEIA-XYA800 | Histone H3 (Phospho-Ser28) ELISA Kit | 2 x 96T | Qualitative | Cultured cells | Inquiry | ||
| DEIA-XYA801 | Histone H3 (Phospho-Thr3) ELISA Kit | 2 x 96T | Qualitative | Cultured cells | Inquiry |
Loading ......
